Previous studies have shown that DPYSL2 is differentially expressed in various tumors, with increased expression in non-small cell lung cancer (NSCLC) (Oliemuller et al., 2013) and colorectal carcinoma (Wu et al., 2008) and decreased expression in breast cancer (Shimada et al., 2014). Here, DPYSL2 is linked to breast carcinoma.